Press Releases
On the 28th March 2022, OncoArendi changed its name to Molecure
OncoArendi has signed a contract agreement with the Polish Agency for Enterprise Development
5 November 2013
The Nencki Institute of Experimental Biology has just signed
6 June 2013
A patent application for the OAT-449
9 April 2013
Funding received for the first discovery program
7 September 2012
The contract was signed with the National Center for Research and Development
18 December 2009
Events & Presentations
ESMO – 8-12 September 2017 Madrid
1 September 2017
ERS – 9-13 September 2017 Milan
1 September 2017
BIO USA – San Diego 19-22 June 2017
1 June 2017
ATS – Washington 19-24 May 2017
1 May 2017
This site is registered on
wpml.org as a development site.
